Wealthfront Advisers
INSM icon

Wealthfront Advisers’s Insmed INSM Stock Holding History

Wealthfront Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
17,511
-893
-5% -$108K ﹤0.01% 624
2026
Q1 		$3.01M Buy
18,404
+8,413
+84% +$1.29M 0.01% 526
2025
Q4 		$1.74M Buy
+9,991
New +$1.82M ﹤0.01% 616

Other funds holding INSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wealthfront Advisers's INSM Position: Q2 2026 in Review

Wealthfront Advisers reduced its Insmed (INSM) stake by 4.9% in Q2 2026, selling an estimated $108K and leaving 17,511 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #624.

Wealthfront Advisers first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.01M in Q1 2026. 393 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Wealthfront Advisers held 17,511 shares of Insmed worth $1.87M as of Q2 2026.
  • Wealthfront Advisers sold 893 Insmed shares in Q2 2026, an estimated $108K.
  • Insmed made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #624 holding.
  • Wealthfront Advisers first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Wealthfront Advisers's Insmed position peaked at $3.01M in Q1 2026.
  • 393 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.